Jason N Dungu
Overview
Explore the profile of Jason N Dungu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
469
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Loganath K, Craig N, Everett R, Bing R, Tsampasian V, Molek P, et al.
JAMA
. 2024 Oct;
333(3):213-221.
PMID: 39466640
Importance: Development of myocardial fibrosis in patients with aortic stenosis precedes left ventricular decompensation and is associated with an adverse long-term prognosis. Objective: To investigate whether early valve intervention reduced...
2.
Rajkumar C, Foley M, Ahmed-Jushuf F, Simader F, Mohsin M, Ganesananthan S, et al.
J Am Coll Cardiol
. 2024 May;
84(1):1-12.
PMID: 38752902
Background: In stable coronary artery disease, 30% to 60% of patients remain symptomatic despite successful revascularization. Perhaps not all symptoms reported by a patient with myocardial ischemia are, in fact,...
3.
Dungu J, Hardy-Wallace A, Dimarco A, Savage H
Curr Heart Fail Rep
. 2024 Mar;
21(4):428-438.
PMID: 38488965
Purpose Of Review: Hypertrophic cardiomyopathy (HCM) is a common inherited cardiac condition with potential for severe complications including sudden cardiac death. Early diagnosis allows appropriate risk stratification and prompt intervention...
4.
Rajkumar C, Foley M, Ahmed-Jushuf F, Nowbar A, Simader F, Davies J, et al.
N Engl J Med
. 2023 Nov;
389(25):2319-2330.
PMID: 38015442
Background: Percutaneous coronary intervention (PCI) is frequently performed to reduce the symptoms of stable angina. Whether PCI relieves angina more than a placebo procedure in patients who are not receiving...
5.
Savage H, Dimarco A, Li B, Langley S, Hardy-Wallace A, Barbagallo R, et al.
Heart
. 2022 Nov;
109(7):511-518.
PMID: 36368882
The management of heart failure with a reduced ejection fraction is a true success story of modern medicine. Evidence from randomised clinical trials provides the basis for an extensive catalogue...
6.
Dungu J, Langley S, Hardy-Wallace A, Li B, Barbagallo R, Field D, et al.
Heart
. 2021 Aug;
108(9):676-682.
PMID: 34417207
Dilated cardiomyopathy (DCM) is a heterogenous group of disorders characterised by left ventricular dilatation and dysfunction, in the absence of factors affecting loading conditions such as hypertension or valvular disease,...
7.
Tayal U, Wage R, Newsome S, Manivarmane R, Izgi C, Muthumala A, et al.
Eur J Heart Fail
. 2020 Feb;
22(7):1160-1170.
PMID: 32056322
Aims: There is an important need for better biomarkers to predict left ventricular (LV) remodelling in dilated cardiomyopathy (DCM). We undertook a comprehensive assessment of cardiac structure and myocardial composition...
8.
Jones R, Karamasis G, Dungu J, Mohdnazri S, Al-Janabi F, Hammersley D, et al.
Cardiol J
. 2020 Feb;
29(1):80-87.
PMID: 32037503
Background: Fractional flow reserve (FFR) assessment of remote arteries, in the context of a bystander chronic total occlusion (CTO), can lead to false positive results. Adenosine stress cardiovascular magnetic resonance...
9.
Jones R, Groom K, Singh A, Lai H, Dungu J, Medeiros F, et al.
Heart Lung Circ
. 2019 Feb;
28(7):e115-e116.
PMID: 30799153
No abstract available.
10.
Halliday B, Wassall R, Lota A, Khalique Z, Gregson J, Newsome S, et al.
Lancet
. 2018 Nov;
393(10166):61-73.
PMID: 30429050
Background: Patients with dilated cardiomyopathy whose symptoms and cardiac function have recovered often ask whether their medications can be stopped. The safety of withdrawing treatment in this situation is unknown....